PHOENIX - Pre-eclampsia in HOspital: Early iNductIon or eXpectant management
- Conditions
- Pre-eclampsia in women between 34+0 and 36+6 weeks of gestationPregnancy and ChildbirthGestational [pregnancy-induced] hypertension with significant proteinuria
- Registration Number
- ISRCTN01879376
- Lead Sponsor
- King's College London
- Brief Summary
2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30691508 protocol (added 31/01/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31472930 results (added 02/09/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34024312/ Results of PEACOCK nested study of prognostic model (added 25/05/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35861912/ Cost-utility analysis (added 22/07/2022) 2022 Funder report results in https://www.journalslibrary.nihr.ac.uk/hta/published-articles/CWWH0622/#/full-report (added 13/12/2022) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38757271/ Secondary analysis of PHOEBE (PHOENIX-3) sub-study data (added 21/05/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 901
Current inclusion criteria as of 05/10/2016:
1. Women between 34+0 and 36+6 weeks of gestation
2. Confirmed as having pre-eclampsia (as defined as defined by International Society for the Study of Hypertension in Pregnancy {ISSHP} 2014 statement)
3. Singleton or dichorionic diamniotic (DCDA) twin pregnancy
4. Aged 18 years or over at the time of screening
5. Able to give written informed consent
Previous inclusion criteria:
1. Women between 34+0 and 36+6 weeks of gestation
2. Confirmed as having pre-eclampsia (as defined by the NICE guidelines on Hypertension in Pregnancy)
3. An in-patient in a consultant-led maternity unit
4. Singleton or dichorionic diamniotic (DCDA) twin pregnancy
5. Aged 18 years or over at the time of screening
6. Able to give written informed consent
Women will be excluded from participating in the study if a decision has already been made to delivery within the next 48 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method